We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$189B
AUM Growth
-$8.13B
Cap. Flow
-$4.44B
Cap. Flow %
-2.35%
Top 10 Hldgs %
23.87%
Holding
8,193
New
1,491
Increased
2,450
Reduced
2,453
Closed
1,365

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.35B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.32B
3
AAPL icon
Apple
AAPL
+$966M
4
NVDA icon
NVIDIA
NVDA
+$768M
5
T icon
AT&T
T
+$594M

Sector Composition

Rank Sector Weight
1 Miscellaneous 59.52%
2 Technology 7.24%
3 Financials 6.69%
4 Healthcare 6.46%
5 Industrials 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDGR icon
3801
Schrodinger
SDGR
$1.47B
$2.03M ﹤0.01%
59,510
-136,784
-70% -$4.15M
CBAN icon
3802
Colony Bankcorp
CBAN
$453M
$2.03M ﹤0.01%
108,655
+55,301
+104% +$998K
NBIS
3803
Nebius Group N.V.
NBIS
$56.9B
$2.03M ﹤0.01%
874,278
+374,105
+75% +$17.8M
FWRG icon
3804
First Watch Restaurant Group
FWRG
$772M
$2.03M ﹤0.01%
155,349
+54,774
+54% +$785K
PHVS icon
3805
Pharvaris
PHVS
$2.48B
$2.03M ﹤0.01%
108,386
-11,172
-9% -$197K
TROW icon
3806
T. Rowe Price
TROW
$23.7B
$2.03M ﹤0.01%
13,410
-113,804
-89% -$17.6M
BHAC
3807
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$2.02M ﹤0.01%
+205,500
New +$2.02M
HCAR
3808
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$2.02M ﹤0.01%
206,459
+8,844
+4% +$86.4K
GOGN.U
3809
DELISTED
GoGreen Investments Corporation Units, each consisting of one Class A ordinary share and one half of one redeemable warrant
GOGN.U
$2.02M ﹤0.01%
200,000
-528,000
-73% -$5.35M
MRO
3810
PUT
DELISTED
Marathon Oil Corporation
MRO
$2.02M ﹤0.01%
+80,500
New +$1.73M
EBACU
3811
DELISTED
European Biotech Acquisition Corp. Units
EBACU
$2.02M ﹤0.01%
205,190
-485,768
-70% -$4.8M
VTR icon
3812
CALL
Ventas
VTR
$47.1B
$2.02M ﹤0.01%
32,700
-134,800
-80% -$7.37M
TRAQ.U
3813
DELISTED
Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant
TRAQ.U
$2.02M ﹤0.01%
200,000
-557,000
-74% -$5.61M
ORIC icon
3814
Oric Pharmaceuticals
ORIC
$1.37B
$2.02M ﹤0.01%
+377,491
New +$3.4M
THR
3815
DELISTED
Thermon Group Holdings
THR
$2.02M ﹤0.01%
124,463
-61,819
-33% -$1.07M
LEVL
3816
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$2.01M ﹤0.01%
50,301
+1,816
+4% +$74.1K
CKPT
3817
DELISTED
Checkpoint Therapeutics
CKPT
$2.01M ﹤0.01%
113,383
+32,578
+40% +$700K
BRCC.WS
3818
CALL
DELISTED
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
$2M ﹤0.01%
+448,070
New +$1.42M
HUMA icon
3819
Humacyte
HUMA
$181M
$2M ﹤0.01%
+283,573
New +$1.65M
BYN.U
3820
DELISTED
Banyan Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant
BYN.U
$2M ﹤0.01%
+200,000
New +$2M
FMTX
3821
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$2M ﹤0.01%
215,141
+163,365
+316% +$1.74M
PSO icon
3822
Pearson
PSO
$10.1B
$2M ﹤0.01%
200,629
-348,642
-63% -$3.15M
SYNA icon
3823
CALL
Synaptics
SYNA
$3.72B
$2M ﹤0.01%
+10,000
New +$2.22M
WTI icon
3824
W&T Offshore
WTI
$539M
$2M ﹤0.01%
522,298
-347,111
-40% -$1.53M
DRI icon
3825
PUT
Darden Restaurants
DRI
$24.5B
$1.99M ﹤0.01%
15,000

Similar funds

Israel Englander's Q1 2022 Portfolio in Review

As of Q1 2022, Israel Englander held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Israel Englander's Q1 2022 filing shows 1,491 new, 2,450 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.

By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 58% a quarter earlier, followed by Technology and Financials.

  • Israel Englander's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
  • Israel Englander added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
  • Israel Englander's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
  • Israel Englander fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
  • Israel Englander's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
  • Israel Englander opened 1,491 new positions and closed 1,365 in Q1 2022.
  • Israel Englander's portfolio value fell 4.1% quarter-over-quarter to $189B.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.